We need to talk about the healthcare sector today. After 2024 had already disappointed many companies in the sector due to the "corona effect" and was labeled a "transition year", I had actually called for a major recovery in 2025. What happened instead is of course clear: a complete bleed-out of the industry.

In fact, the situation in the healthcare sector is so bad that no returns at all have been achieved across the board in the last three years, and that is bad.

I had actually chosen the healthcare sector as a second pillar in my portfolio alongside my tech investments, as I have a great passion for the topic of healthcare and also like to spend a lot of time on it. Actually, I also had the impression that the healthcare sector is rather defensive as the demand for healthcare services is continuously increasing when there is an increasing number of sicker people in the world. I have therefore created a diversified portfolio of companies that have a predominance in the treatment of a specific disease: Heart defects, mucoviscidosis, diabetes - you can probably already guess where this is going.

At the moment I have several companies in my portfolio whose performance really resembles a horror movie: $ILM1 (-1,43 %) , $AFX (+0,12 %) , $UNH (-0,25 %) , $NOVO B (+0,98 %)

Plus some resurrected zombies like $TMO (-2,24 %) , $ABBV (-0,21 %) , $EW (-0,47 %) , $MEDP (-1,37 %) whose performance could be reactivated through life-sustaining measures.

Only $SYK (-0,77 %) and $VRTX (+0,31 %) are developing in line with expectations overall.

In summary, 40% pain, 40% okay and only 20% yes

However, the poor performance is not at all related to the selection of companies. Other giants such as $MRK (-2,48 %) and even the most solid healthcare company in the world $JNJ (-0,64 %) are not performing satisfactorily either. Some people here in the comments always act as if Novo Nordisk and UNH were the worst companies in the world and everything was foreseeable - but that's just not the case. In fact, they are only falling so sharply and getting so much media coverage because they have always been regarded as the absolute gems in contrast to solala companies like $PFE (-3,59 %) it really wasn't an everyday occurrence for them to halve overnight.

Overall, the healthcare sector, which has been battered for years, is now also considered undervalued. So we can still hope for a recovery. Nevertheless, it is slowly becoming a huge problem for me if I put 1/4 of my capital into assets that are outperforming the savings book and not compensating for inflation. The opportunity costs in particular are astronomical, as I have been 80% right in the tech sector in recent years and 80% wrong in the healthcare sector. I spend more money with my left hand than I earn with my right.

The saying comes to mind: "The tide lifts all boats" which is actually supposed to protect against overconfidence. But isn't it also true that an ebb tide lowers all boats? Perhaps neither the great hit rate in the tech sector nor the subterranean hit chance in the health sector is dependent on my investment decisions, but simply a static anomaly.

What I also want to address specifically is that I find it incredibly annoying that investing in the healthcare sector is such a drama club. I sometimes wonder whether we're doing business here or filming a telenovela. I mean, the whole thing with $HIMS (+6,6 %) is a complete kindergarten. Why is it that in the automotive industry, complete strangers manage to merge or form alliances just like that and in the healthcare industry they can't even manage to sell a few medications for 3 months without it degenerating into a mud fight and a war of the roses? My gosh.

But now it's up to you. I would be particularly interested to know how people who have been on the market for more than 10 years see it. Have health values always been such a rollercoaster ride or is the industry better than its reputation?

$XDWH (-0,97 %)
$XLV (-1,06 %)
$CSPX (-0,1 %)
$VUSA (-0,11 %)
$UNH (-0,25 %)
$OSCR

According to Goldman Sachs, healthcare is the only sector in the S& P 500 that is cheaper than the 10- and 30-year averages.

This is an extremely attractive risk/reward ratio and the coming months will be exciting.

$ELV (-1,02 %)
$CNC (-2,37 %)
$DHR (-2,94 %)
$SRT (+0,13 %)
$LLY (-0,45 %)
$NOVO B (+0,98 %)
$NVO (+1,35 %)
$ISRG (-2,09 %)
$JNJ (-0,64 %)
$ABBV (-0,21 %)
$PFE (-3,59 %)
$SAN (-0,74 %)
$MRK (-2,48 %)
$BMY (-3,22 %)
$TMO (-2,24 %)

TL;DR like to roast my deposit, appreciate all opinions!

I always find the many posts here and reading various biographies very interesting, so I've wanted to say a few words for a while now.

Tried early, but started late

I am now 32 and unfortunately started investing seriously far too late, studied far too long, and with the larger salaries finally built up as much as possible and tried to catch up as quickly as possible. "Unfortunately" means for the most part the past calendar year, which is why I put a large part of my money into shares at already high prices and then had very little cash left in the crash to add to it. Fully invested, in other words. During the crash, I mainly reallocated and continued to fully invest what was left over from my monthly salaries.

Yet back in 2011, at the age of 18, I had a share called Facebook and a Starbucks share in my portfolio without much of a clue. I just wanted to know what my mother was actually doing with her shares and how it worked, and with FB and Starbucks I simply chose two companies that "everyone" uses/needs anyway. The idea wasn't that stupid, it worked, and after a short time I was happy about the small profit in absolute terms, sold the shares at DiBa despite the high fees at the time and simply forgot about shares for years - wealth accumulation, a word that wasn't in my vocabulary, the money I had was simply turned upside down as a young adult. Well, young me, just leave the shares lying around or, even better, take a closer look at them and carry on, it "might" have been worth it...

Of priorities and wrong horses

The years went by without any shares, but with lots of fast food and partying, but at least things have changed. At some point, I started to think about the future and wealth accumulation, first taking an interest in interest rates, and then the logical next step was dividends and shares. Unfortunately, it started rather haphazardly. As a student, I started investing small amounts, and of course betting on the wrong horses. Speculative lithium shares were particularly bad in this phase, unfortunately these were large sums even by my standards, from my grandfather's estate. That was bad. However, crypto was a very good horse, more precisely $BTC (-0 %) and $ETH (+0,06 %) which (as a computer scientist) I became interested in early on and exited several times with high profits, also thanks to domestic mining. It's just stupid that back then, in the last decade, I would never have imagined how cryptos would develop. If I had, I would have simply left it all, or at least part of it. You learn and you're always smarter afterwards anyway.

Fully invested - excessive, unhealthy, or simply good housekeeping?

So now I'm 32 - and proud of a portfolio that I think I've built up to a good size in a relatively short time. Which has given me other ideas for some time now. I'm still a long way from reaching my goal, but I have to get back on the "invest 100%" path, which has been completely contrary to my past for a long time now, and strangely enough, I'm finding it difficult to do so - something to reflect on. There are too many (supposed?) opportunities every day. So I simply could not $UNH (-0,25 %) after a long period of observation yesterday and of course the savings plans had to run today too. I think I've always been good at budgeting, or let's put it this way, at least good at getting by with the money available to me in a perfectly timed way, but "indulging", not just in company shares, may become a little more prominent again. I don't go without noticeably in everyday life, I need very little, which I don't think is a bad quality to begin with. But I have changed a lot in the area of "consumption" compared to the past. I think it would be good to find a healthy balance. In my opinion, just as you don't just live to work, but work to live, the same applies to saving/investing. I actually read a post here on gq today that described exactly that and I could relate to it very well. So, reflection and taking your foot off the gas is allowed - no, it's a must! I am familiar with frugalists, but I never wanted to be one. I'd be interested to know if anyone else here feels the same way, or did?

Wrong decisions, mistakes... and (hopefully) the right conclusions

Back to the topic! (Not only) on the way to today's portfolio I have made many wrong decisions, as already mentioned, so I thought that a well-kept portfolio roast could do me some good. Other, new opinions and assessments can't be bad!

In particular, in the past I have often missed the opportunity to simply let profits run their course and instead dragged losses around with me for too long (which brings us back to lithium). A thought that I recently had again when I was thinking about when it would make sense to $HIMS (+6,6 %) possibly realize, as an example. $PLTR (+4,15 %) and $NVDA (+0,32 %) are two examples that, like so many others, I naturally had on my radar, but they always seemed too expensive, the setback never came and I really missed the big rallies as a result. At the same time, I also get caught out by FOMO from time to time. So in both good and bad phases, I try not to just see red or green, fear or hope, but simply to evaluate what actually makes sense "from now on". Sometimes you realize a loss in order to try your luck elsewhere, sometimes you should let profits run, sometimes take them, sometimes endure the dip, sometimes be courageous and sometimes defensive. Easier said than done. I find it very nice and helpful to exchange ideas on this platform and how open and "yet" respectful it generally is. Of course, I will most likely never reach some portfolio sizes, but you can always learn something about how some people manage their portfolios, regardless of the absolute figures. You will always make mistakes, but at least you should deal with them correctly and draw the best possible conclusions.

Portfolio restructuring, planned investments / savings plans

And today? After some evaluation, research, regrouping and restructuring, I now have fewer, but still quite a few positions in different sectors, most of which are already of a decent and roughly balanced size. My medium-term plan is now to build up all positions to a certain target size. This is why I am currently running savings plans:

$MPWR (-0,74 %)

$AVGO (+0,14 %)

$ISRG (-2,09 %)

$DXCM (+0,32 %)

$DHR (-2,94 %)

$ALV (+0,48 %)

$9988 (+0,34 %)

$BRK.B (-0,56 %)

$APH (-0,32 %)

$MELI (+0,07 %)

$BLK (-1,22 %)

$RSG (-1,62 %)

$DGE (-0,45 %)

$VKTX (-2,96 %)

ETF/ETC:

$UBU7 (-0,23 %)

$EWG2 (+0,31 %)

Partly with small weekly amounts, until enough cash is available to fill the target position evenly. With $AVGO (+0,14 %) for example, there is not much left. Also $BRK.B (-0,56 %) / $APH (-0,32 %) and others are already approaching the target. In some cases with somewhat larger sums for still small but prioritized positions, until opportunities and/or resources for individual purchases arise, such as the $ALV (+0,48 %) and $RSG (-1,62 %) should be mentioned here, as well as $DGE (-0,45 %) as a turnaround candidate.

Once the aforementioned positions are full, I would like to turn my attention to the more defensive candidates that are already in the portfolio but which I am currently prioritizing - $MCD (-0,63 %) / $KO (-1 %) / $CCEP (-0,39 %) / $ULVR (-0,06 %) and others - and finally increase the ETF and gold share in the long term.

$VKTX (-2,96 %) is a bit of a gamble, as I have actually said goodbye to pharma - $ABBV (-0,21 %) / $NOVO B (+0,98 %) / $LLY (-0,45 %) and $MRK (-2,48 %) were still part of the inventory until recently. Instead, I decided to go with $DXCM (+0,32 %) / $ISRG (-2,09 %) / $DHR (-2,94 %) on medical technology.

$BTC (-0 %) remains a fixed value in the portfolio, while I $ETH (+0,06 %) (incorrectly entered due to staking - around 0.4 shares or €1000) and $XRP (-0,27 %) would/will sell at corresponding prices.

I still lack around €15,000 in individual stocks at current prices to bring all positions to the current desired/dream target. This will take some time, but is foreseeable. And then I would be really quite proud and happy "as things stand now"! In any case, I now feel very comfortable on the path I have chosen and, as I said, I have to stop myself from forgetting that not all money has to be invested all the time.

Savings rate

To put this into figures, I have averaged a savings rate of around €1500 over the last 24 months, with an average of €100 a month in dividends. 1400€ investment, that's about 82% of my monthly budget after deducting all "unavoidable" fixed costs including fuel and household, but not including consumption such as clothes, going out or vacations. Exaggerated, I can't say otherwise myself. But at least I have a good reason to step on the gas and get the compound interest going.

So what is all this for?

In the long term, my girlfriend and I dream of owning a property somewhere on the Croatian Adriatic, her homeland, and where I was able to spend many wonderful weeks with my parents every year as a child. A beautiful region that I consider an important part of my life, with many great moments and memories that may become even more. I hope to get closer to this goal "quickly" with the depot. The language is already halfway there! :)

In the long term, this would probably involve a little reallocation into value dividend payers, which should help with repayment. However, I would also like to lay the foundations for later distributions today, without neglecting growth. There is probably no perfect mix for this, but you are welcome to rate mine.

So, unfortunately I was once again unable to be brief. Thank you for reading, whoever has made it this far, and for your comments! I'm very excited and wish you all a great weekend.

🍊 is getting serious: planned cost reductions of 30-80% are being implemented by US pharmaceutical giants such as $JNJ (-0,64 %) , $ABBV (-0,21 %) and $LLY (-0,45 %) under massive pressure. This is certainly a step in the right direction for the population - drug prices in the USA were sometimes really beyond good and evil.

But of course bitter from an investor's point of view. The big pharmaceutical stocks could take a big hit.

It will be interesting to see whether foreign companies such as $NOVO B (+0,98 %) and Co will also be dragged down by this.

Personally, I don't currently have any individual pharma positions (only via ETFs), but I am planning to build something up in the long term - just not in this phase of uncertainty.

What's your situation? Are you invested in the US pharma segment and can withstand a possible price slide?

#trump
#pharma
#us
#usa

AbbVie receives EU approval for RINVOQ in giant cell arteritis

AbbVie $ABBV (-0,21 %) has great news from Europe: The European Commission (EC) has approved RINVOQ® (upadacitinib) for the treatment of adults with giant cell arteritis (GCA). This approval marks a significant step as it is the first oral therapy of its kind to be launched in the EU. The decision is based on the impressive results of the phase 3 SELECT-GCA study. Here, 46.4% of patients taking RINVOQ showed a sustained remission of the disease, compared to only 29% in the placebo group. Another plus point: the therapy enables less steroid exposure, which brings relief to many patients, as the side effects of steroid treatments are often burdensome. With this new indication, AbbVie is further expanding its position in the therapeutic area and demonstrating the importance of innovative approaches in medicine.

Levi's plans price increases due to US tariffs

In the USA, Levi Strauss $LEVI (-0,43 %) is confronted with a challenging situation: The potential price increases caused by President Donald Trump's tariffs could drive up the price of the brand's popular jeans. The company faces the challenge of coping with the increased costs without unduly burdening customers. It is considering how to adjust its pricing strategy in order to remain competitive. These considerations are particularly important in a highly competitive market in which every price increase harbors both opportunities and risks. Levi's must carefully consider how to respond to external economic factors in order to continue to successfully position its brand in the US market.

Sources:

https://www.finanzen.net/nachricht/aktien/abbvie-announces-european-commission-approval-of-rinvoq-upadacitinib-for-the-treatment-of-adults-with-giant-cell-arteritis-14375484

https://www.finanzen.net/nachricht/aktien/levi-strauss-aktie-levi-s-erwaegt-nach-us-zoellen-preiserhoehungen-in-us-markt-14375449

European defense stocks rise after Selensky-Trump dispute

Shares in the defense industry experienced a strong upswing on Monday, and there are good reasons for this. The trigger was the scandal between Ukrainian President Volodymyr Selenskyj and US President Donald Trump, which brought talks on a raw materials agreement and security guarantees to a standstill. This uncertainty has prompted investors to bet on defense stocks in the expectation that defense spending in Europe will increase.

Rheinmetall $RHM (+0,57 %) reached a new record high in the DAX and closed with an impressive gain of 13.71% at EUR 1,144.50. This means that the share has already gained 80 percent since the beginning of the year. HENSOLDT $HAG also benefited from the general euphoria and closed up 22.25 percent at 64.00 euros. Shares in thyssenkrupp $TKA (+1,15 %) rose by 10.57 percent to 8.41 euros, while RENK $ABBV (-0,21 %) rose by 18.90 percent to 35.52 euros.

Analysts agree that geopolitical tensions and uncertainty over US policy will boost defense spending in Europe. Jürgen Molnar from RoboMarkets emphasizes that the world has changed after the scandal and that Europe can no longer count on the USA as a reliable partner. JPMorgan analyst David Perry points out that many NATO countries will increase their defense spending in the near future, which could further boost demand for defense stocks.

Forecast: Aramco expects results

Saudi Aramco $2222 is about to announce results for the quarter ending December 31, 2024. Analysts estimate that earnings per share will come in at 9.3 cents, down from 11 cents in the same quarter last year.

For sales, analysts expect a decline to an average of EUR 103 billion, which corresponds to a decrease of 11.69 percent compared to the previous year. Last year, Aramco recorded sales of EUR 117 billion. For the past fiscal year, analysts expect earnings of EUR 0.42 per share, compared with EUR 0.48 per share in the previous year. Total sales are estimated at EUR 450 billion, which also represents a decline compared to last year.

Sources:

https://www.finanzen.net/nachricht/aktien/trump-selenskyj-streit-renk-hensoldt-thyssenkrupp-leonardo-rheinmetall-aktien-co-profitieren-stark-von-sondervermoegen-diskussion-14285430

https://www.finanzen.net/nachricht/aktien/aktie-im-fokus-ausblick-aramco-saudi-aramco-gibt-ergebnis-zum-abgelaufenen-quartal-bekannt-14285220

My dividend portfolio will soon be one year old. It now consists of 8 positions, each of which is saved with €18 per month.

My latest additions are $CTAS (-1,59 %) and $ABBV (-0,21 %)

How do you like my portfolio composition?